| Title: | Disentangling the consequences of type 2 diabetes on targeted metabolite profiles using causal inference and interaction QTL analyses |
| Journal: | PLOS Genetics |
| Published: | 3 Dec 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39625957/ |
| DOI: | https://doi.org/10.1371/journal.pgen.1011346 |
| URL: | https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1011346&type=printable |
Publication 14060
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Circulating metabolite levels have been associated with type 2 diabetes (T2D), but the extent to which T2D affects metabolite levels and their genetic regulation remains to be elucidated. In this study, we investigate the interplay between genetics, metabolomics, and T2D risk in the UK Biobank dataset using the Nightingale panel composed of 249 metabolites, 92% of which correspond to lipids (HDL, IDL, LDL, VLDL) and lipoproteins. By integrating these data with large-scale T2D GWAS from the DIAMANTE meta-analysis through Mendelian randomization analyses, we find 79 metabolites with a causal association to T2D, all spanning lipid-related classes except for Glucose and Tyrosine. Twice as many metabolites are causally affected by T2D liability, spanning almost all tested classes, including branched-chain amino acids. Secondly, using an interaction quantitative trait locus (QTL) analysis, we describe four metabolites consistently replicated in an independent dataset from the Estonian Biobank, for which genetic loci in two different genomic regions show attenuated regulation in T2D cases compared to controls. The significant variants from the interaction QTL analysis are significant QTLs for the corresponding metabolites in the general population but are not associated with T2D risk, pointing towards consequences of T2D on the genetic regulation of metabolite levels. Finally, through differential level analyses, we find 165 metabolites associated with microvascular, macrovascular, or both types of T2D complications, with only a few discriminating between complication classes. Of the 165 metabolites, 40 are not causally linked to T2D in either direction, suggesting biological mechanisms specific to the occurrence of complications. Overall, this work provides a map of the consequences of T2D on Nightingale targeted metabolite levels and on their genetic regulation, enabling a better understanding of the T2D trajectory leading to complications.</p>
12 Keywords
- Diabetes Mellitus, Type 2
- Genetic Predisposition to Disease
- Genome-Wide Association Study
- Humans
- Lipids
- Lipoproteins
- Mendelian Randomization Analysis
- Metabolome
- Metabolomics
- Polymorphism, Single Nucleotide
- Quantitative Trait Loci
- United Kingdom
13 Authors
- Ozvan Bocher
- Archit Singh
- Yue Huang
- Urmo Võsa
- Ene Reimann
- Ana Arruda
- Andrei Barysenska
- Anastassia Kolde
- Nigel W. Rayner
- Estonian Biobank research team
- Tõnu Esko
- Reedik Mägi
- Eleftheria Zeggini
1 Application
| Application ID | Title |
|---|---|
| 10205 | Cardiometabolic trait genetics |
Enabling scientific discoveries that improve human health